Bioclinica®, a world-leading provider of specialty clinical trial services, has appointed David Herron as the company’s next Chief Executive Officer, effective January 2, 2018. This …
Bioclinica®, the world-leading provider of technology-enabled solutions for clinical research, today announces the launch of Bioclinica Clinical Adjudication, a transformational offering in which medical specialists …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
